Search company, investor...

Founded Year

2005

Stage

Series E - II | Alive

Total Raised

$90.65M

Last Raised

$1.4M | 4 yrs ago

About Adastra Pharmaceuticals

Adastra Pharmaceuticals is a clinical-stage biopharmaceutical company with a primary focus on oncology. The company is dedicated to developing innovative treatments for aggressive forms of cancer. Its primary customer base is within the healthcare industry, specifically those dealing with oncology. Adastra Pharmaceuticals was formerly known as Tragara Pharmaceuticals. It was founded in 2005 and is based in Princeton, New Jersey.

Headquarters Location

202 Carnegie Center Suite 104

Princeton, New Jersey, 08540,

United States

760-208-6900

Loading...

Loading...

Adastra Pharmaceuticals Patents

Adastra Pharmaceuticals has filed 4 patents.

The 3 most popular patent topics include:

  • experimental cancer drugs
  • transcription factors
  • acute myeloid leukemia
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/12/2020

11/16/2021

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Grant

Application Date

8/12/2020

Grant Date

11/16/2021

Title

Related Topics

Transcription factors, Brain tumor, Oncology, Radiation therapy, Experimental cancer drugs

Status

Grant

Latest Adastra Pharmaceuticals News

Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals

Oct 6, 2021

Cothera to Advance Clinical Development of Oral Kinase Inhibitor with Unique Myc Depletion I want to thank all the physicians and dedicated healthcare providers who have put forward relentless effort on behalf of their patients as the Adastra team transitions zotiraciclib into Cothera.” — Scott Megaffin, Chief Executive Officer, Adastra PRINCETON, NEW JERSEY, USA, October … Continue reading "Cothera Bioscience Acquires Zotiraciclib from Adastra Pharmaceuticals"

Adastra Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Adastra Pharmaceuticals founded?

    Adastra Pharmaceuticals was founded in 2005.

  • Where is Adastra Pharmaceuticals's headquarters?

    Adastra Pharmaceuticals's headquarters is located at 202 Carnegie Center, Princeton.

  • What is Adastra Pharmaceuticals's latest funding round?

    Adastra Pharmaceuticals's latest funding round is Series E - II.

  • How much did Adastra Pharmaceuticals raise?

    Adastra Pharmaceuticals raised a total of $90.65M.

  • Who are the investors of Adastra Pharmaceuticals?

    Investors of Adastra Pharmaceuticals include Domain Associates, ProQuest Investments, Mitsubishi, Rusnano, Morgenthaler Ventures and 7 more.

  • Who are Adastra Pharmaceuticals's competitors?

    Competitors of Adastra Pharmaceuticals include Reata Pharmaceuticals, Viracta, Vaccinex, Bexion Pharmaceuticals, Solasia Pharma and 7 more.

Loading...

Compare Adastra Pharmaceuticals to Competitors

A
Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

V
Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

VGXI Logo
VGXI

VGXI is a contract manufacturer of plasmid DNA. The company delivers flexibility, experience, reliability, and value to clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews.

K
Kanisa Pharmaceuticals

Kanisa Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of therapeutics in the field of oncology.

D
Diasome Pharmaceuticals

Diasome Pharmaceuticals develops hepatocyte-directed vesicle technology. Its cell targeting platform illuminates an understanding of diabetes. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short-acting insulin; and HDV-B, an injectable basal long-acting insulin. Diasome Pharmaceuticals was founded in 2004 and is based in Cleveland, Ohio.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.